by STREAM admin
The persistence and burden of flagging drug development paradigms: An exploratory analysis of VEGF Inhibition in breast cancer [Timestamp]
Can Cancer Experts Accurately Forecast the Replication of Cancer Biology Experiments? [.pdf]
Uncertainties and risk in planning translational trials
Can Researchers Accurately Predict Trial Outcomes? An Empirical Investigation
Publication of Trials Involving Unsuccessful Interventions: An Empirical and Ethical Analysis
Animals, Humans, and the Continuity of Evidence: A Study of Clinical Translation [.pdf]
An Ethical Analysis of Risk, Design and Prediction
Evolution of Biomarker Evidence in Personalized Cancer Medicine
How Researchers Decide Trial Initiation in Novel Research Arenas
Relationship Between Preclinical and Clinical Outcomes in Pain Drug Development
Concordance between preclinical and clinical outcomes and laboratory practices
How well can pre-clinical stroke researchers replicate effect sizes in their experiments? A meta-analysis of “accidental replications” [Timestamp]
An Audit Of Validity Threats In The Design And Publication Of Predictive And Prognostic Cancer Studies [Timestamp]
What is the real cost of cancer drug development? [Timestamp]
How Targeted is Personalized Drug Development? The Translation Trajectories of Imatinib, Dasatinib and Nilotinib [Timestamp]
How well can pre-clinical stroke researchers replicate effect sizes in their experiments? A metaanalysis of “accidental replications” [Timestamp]
BibTeX
@Manual{stream2013-279,
title = {Projects},
journal = {STREAM research},
author = {STREAM admin},
address = {Montreal, Canada},
date = 2013,
month = jul,
day = 7,
url = {http://www.translationalethics.com/projects/}
}
MLA
STREAM admin. "Projects" Web blog post. STREAM research. 07 Jul 2013. Web. 14 Jul 2020. <http://www.translationalethics.com/projects/>
APA
STREAM admin. (2013, Jul 07). Projects [Web log post]. Retrieved from http://www.translationalethics.com/projects/
